Customised CXL Trial

Daniel Gore leads a new Clinical trial

Customised CXL Trial

TransPRK laser treatments have been successful both in trials and practice at improving visual outcomes in patients with Keratoconus. There has been evidence to show that cross-linking alone, when preformed in a more targeted way can have a similar effect. But is it predictable? A new clinical trial headed by Daniel Gore aims to find out. The Customised CXL Trial using the latest PiXL device from Avedro is about to kick off at Moorfields Eye Hospital.

We will be posting more information on this exciting new clinical trial soon.

About the Author

Marcello Leucci

Marcello Leucci

In addition to working with Dan, Marcello is the lead optometrist of the Keratoconus service at Moorfields Eye Hospital. He is responsible for development of protocols on keratoconus monitoring and progression criteria and is actively involved in research in corneal tomography, and the effectiveness of both new and existing treatments for the condition. 

Leave a comment

You are commenting as guest. Optional login below.


Copyright © Daniel Gore 2019
Website design & build by Marcello Leucci

Contact Us        |        Cookies